Imaging of Ulcerative Colitis: The Role of Diffusion-Weighted Magnetic Resonance Imaging.
Ali S AlyamiPublished in: Journal of clinical medicine (2024)
Magnetic resonance imaging (MRI) has emerged as a promising and appealing alternative to endoscopy in the objective assessment of patients with inflammatory bowel disease (IBD). Diffusion-weighted imaging (DWI) is a specialized imaging technique that enables the mapping of water molecule diffusion within biological tissues, eliminating the need for intravenous gadolinium contrast injection. It is expanding the capability of traditional MRI sequences in Ulcerative Colitis (UC). Recently, there has been growing interest in the application of intravoxel incoherent motion (IVIM) imaging in the field of IBD. This technique combines diffusion and perfusion information, making it a valuable tool for assessing IBD treatment response. Previous studies have extensively studied the use of DWI techniques for evaluating the severity of activity in IBD. However, the majority of these studies have primarily focused on Crohn's disease (CD), with only a limited number of reports specifically examining UC. Therefore, this review briefly introduces the basics of DWI and IVIM imaging and conducts a review of relevant studies that have investigated its application in UC to show whether these techniques are useful techniques for evaluating patients with UC in terms of detection, characterization, and quantification of disease activity. Through the extensive literature survey, most of these studies indicate that DWI proves valuable in the differential diagnosis of UC and could be used as an effective modality for staging UC.
Keyphrases
- contrast enhanced
- diffusion weighted imaging
- diffusion weighted
- magnetic resonance imaging
- ulcerative colitis
- high resolution
- magnetic resonance
- computed tomography
- disease activity
- case control
- systemic lupus erythematosus
- systematic review
- rheumatoid arthritis
- patients with inflammatory bowel disease
- mass spectrometry
- low dose
- fluorescence imaging
- high dose
- healthcare
- electronic health record
- multidrug resistant
- ankylosing spondylitis
- single molecule